Lobular Carcinoma in Situ
📧 Sign up to get email alerts when something new happens for Lobular Carcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer [Phase 1]
This is a Phase I prevention trial evaluating atorvastatin in women at increased risk for breast cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial [Phase 1]
Phase 1 proof-of-principle trial evaluating SOM230 (pasireotide) as an IGF-I action inhibitor for breast cancer chemoprevention in high-risk…
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Molecular Breast Imaging in Women With Atypia and LCIS [NA]
The Mayo Clinic-led clinical trial evaluating molecular breast imaging for women with atypical lobular hyperplasia, atypical ductal hyperpla…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer [NA]
This trial evaluated gene-expression-guided selection of neoadjuvant therapy for breast cancer patients before surgery, comparing hormone th…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer [NA]
The study reports that a group-based lifestyle intervention completed and collected biomarker data in participants at high risk for breast c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-07-16Clinical Trial Update: "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" [Phase 2]
Phase II clinical trial evaluating PET-guided neoadjuvant chemotherapy and Oncotype-guided hormonal therapy for breast cancer.